A Review of Nebivolol Pharmacology and Clinical Evidence

Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies

(2015) Augusto C. Montezano et al.   CANADIAN JOURNAL OF CARDIOLOGY

Nebivolol: Vasodilator Properties and Evidence for Relevance in Treatment of Cardiovascular Disease

(2014) Jonathan G. Howlett   CANADIAN JOURNAL OF CARDIOLOGY

Nebivolol, But Not Metoprolol, Lowers Blood Pressure in Nitric Oxide–Sensitive Human Hypertension

(2014) Luis E. Okamoto et al.   HYPERTENSION

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

(2014) Thomas D Giles et al.   LANCET

Economic impact of switching from metoprolol to nebivolol for hypertension treatment: a retrospective database analysis

(2014) Stephanie Chen et al.   JOURNAL OF MEDICAL ECONOMICS

Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial

(2013) Robert J. Weiss et al.   American Journal of Cardiovascular Drugs

Both Carvedilol and Nebivolol May Improve Platelet Function and Prothrombotic State in Patients With Nonischemic Heart Failure

(2013) Mustafa Karabacak et al.   ANGIOLOGY

Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: A multicenter, randomized, double-blind study

(2013) Josep Redón et al.   BLOOD PRESSURE

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

(2013) Clyde W. Yancy et al.   CIRCULATION

Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?

(2013) Georgios Bouras et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: The CARNEBI trial

(2013) Mauro Contini et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

(2013) Paul A. James et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Nebivolol Monotherapy in Younger Adults (Younger Than 55 Years) With Hypertension: A Randomized, Placebo-Controlled Trial

(2013) Thomas D. Giles et al.   Journal of Clinical Hypertension

Effects of Nebivolol on Aortic Compliance in Patients With Diabetes and Maximal Renin Angiotensin System Blockade: The EFFORT Study

(2013) Alexandros Briasoulis et al.   Journal of Clinical Hypertension

Clinical Practice Guidelines for the Management of Hypertension in the Community

(2013) Michael A. Weber et al.   Journal of Clinical Hypertension

Benefits of   blockers in patients with heart failure and reduced ejection fraction: network meta-analysis

(2013) S. Chatterjee et al.   BMJ-British Medical Journal

Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension

(2012) Qiuping Gu et al.   CIRCULATION

Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS

(2012) Bart A. Mulder et al.   EUROPEAN JOURNAL OF HEART FAILURE

Blood Pressure Effects of Combined β-Blocker and Angiotensin-Converting Enzyme Inhibitor Therapy Compared With the Individual Agents: A Placebo-Controlled Study With Nebivolol and Lisinopril

(2012) Michael A. Weber et al.   Journal of Clinical Hypertension

Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension

(2012) Martin Serg et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Efficacy and Tolerability of Nebivolol in Stage I–II Hypertension: A Pooled Analysis of Data From Three Randomized, Placebo-Controlled Monotherapy Trials

(2011) Robert J. Weiss et al.   CLINICAL THERAPEUTICS

Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study

(2011) Viviane M. Conraads et al.   EUROPEAN JOURNAL OF HEART FAILURE

Differential Effects of Nebivolol and Metoprolol on Central Aortic Pressure and Left Ventricular Wall Thickness

(2011) Priit Kampus et al.   HYPERTENSION

Comparative Long Term Effects of Nebivolol and Carvedilol in Hypertensive Heart Failure Patients

(2011) Giuseppe Marazzi et al.   JOURNAL OF CARDIAC FAILURE

β-Blockade: Benefits Beyond Blood Pressure Reduction?

(2011) John R. Cockcroft et al.   Journal of Clinical Hypertension

Reversal of subclinical left ventricular dysfunction by antihypertensive treatment: a prospective trial of nebivolol against metoprolol

(2011) Dragos Vinereanu et al.   JOURNAL OF HYPERTENSION

The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension

(2011) Ramprasad Kandavar et al.   Journal of the American Society of Hypertension

Erectile Dysfunction in High-Risk Hypertensive Patients Treated with Beta-Blockade Agents

(2010) Alberto Cordero et al.   Cardiovascular Therapeutics

Effects of β-blockers on glucose and lipid metabolism

(2010) Vivian A. Fonseca   CURRENT MEDICAL RESEARCH AND OPINION

Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness

(2010) Charalambos Vlachopoulos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension

(2010) Alberto Cordero et al.   POSTGRADUATE MEDICINE

Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study

(2009) Otto Kamp et al.   Clinical Research in Cardiology

What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?

(2009) Michala E Pedersen et al.   CURRENT OPINION IN CARDIOLOGY

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial

(2009) Alain Cohen-Solal et al.   EUROPEAN JOURNAL OF HEART FAILURE

Role of Pulse Pressure Amplification in Arterial Hypertension

(2009) Alberto P. Avolio et al.   HYPERTENSION

Evolving Mechanisms of Action of Beta Blockers: Focus on Nebivolol

(2009) R Preston Mason et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Nebivolol in Obese and Non-Obese Hypertensive Patients

(2009) Camila Manrique et al.   Journal of Clinical Hypertension

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I–II hypertension

(2009) J M Neutel et al.   JOURNAL OF HUMAN HYPERTENSION

A comparison of atenolol and nebivolol in isolated systolic hypertension

(2009) Zahid Dhakam et al.   JOURNAL OF HYPERTENSION

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction

(2009) Dirk J. van Veldhuisen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nebivolol

(2009) Thomas Münzel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

β-Blocker Use for the Stages of Heart Failure

(2009) Marc Klapholz   MAYO CLINIC PROCEEDINGS

Comparison of Nebivolol Monotherapy Versus Nebivolol in Combination With Other Antihypertensive Therapies for the Treatment of Hypertension

(2008) Vasilios Papademetriou   AMERICAN JOURNAL OF CARDIOLOGY

Nebivolol Treatment Reduces Serum Levels of Asymmetric Dimethylarginine and Improves Endothelial Dysfunction in Essential Hypertensive Patients

(2008) A. F. Pasini et al.   AMERICAN JOURNAL OF HYPERTENSION

 -Blockers Reduce Aortic Stiffness in Hypertension but Nebivolol, Not Atenolol, Reduces Wave Reflection

(2008) A. Mahmud et al.   AMERICAN JOURNAL OF HYPERTENSION